Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
11 hedge funds and large institutions have $1.65M invested in Innovator IBD ETF Leaders ETF in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
15% less funds holding
Funds holding: 13 → 11 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
67% less capital invested
Capital invested by funds: $4.97M → $1.65M (-$3.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGAM
Princeton Global Asset Management
Princeton,
New Jersey
|
+$92.4K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$82.5K |
| 3 |
Koshinski Asset Management
Decatur,
Illinois
|
+$57.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.11K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$4.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.27M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$755K |
| 3 |
Jane Street
New York
|
-$717K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$201K |
| 5 |
LPL Financial
San Diego,
California
|
-$73.5K |
LDRS Hedge Fund Activity: Q1 2019 in Review
11 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2019, worth a combined $1.65M — down 67% from $4.97M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of LDRS and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Princeton Global Asset Management, opening a new position worth an estimated $92.4K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.27M sold.
- 11 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2019, down from 13 in Q4 2018.
- Funds reported $1.65M of Innovator IBD ETF Leaders ETF stock for Q1 2019, down 67% quarter-over-quarter.
- 2 funds opened new Innovator IBD ETF Leaders ETF positions in Q1 2019 and 4 closed out, a net change of -2 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q1 2019 was Princeton Global Asset Management, an estimated $92.4K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q1 2019 was Susquehanna International Group, an estimated $1.27M sold.
Based on aggregated 13F filings for Q1 2019.